论文部分内容阅读
目的探讨累及重要血管的原发或复发性腹膜后肿瘤切除及受侵犯重要血管的处理方法,以提高肿瘤切除率。方法总结自1994年7月至2007年6月,86例累及重要血管的原发或复发性腹膜后肿瘤切除及血管重建的经验。结果获随访81例,随访时间1~157个月,平均6.8年。81例人工血管移植病人中,移植物血栓栓塞4例,其中1例左髂动脉移植术后8个月发生血栓栓塞延误就诊左下肢坏疽行左髂关节解脱。3例术后7~12个月髂静脉移植物血栓栓塞,肢体稍肿胀。生存期>1年者74例,>3年者61例,>5年者39例,其余病例尚在随访中。随访中11例肿瘤复发再次切除。结论切除累及重要血管的原发或复发性腹膜后肿瘤并大血管重建,手术安全,可明显提高切除率,降低复发率,延长存活时间。
Objective To investigate the treatment of major or recurrent retroperitoneal tumors involving important blood vessels and invasion of important blood vessels in order to improve the tumor resection rate. Methods From July 1994 to June 2007, 86 cases of primary or recurrent retroperitoneal tumor resection and revascularization involving major vessels were summarized. The results were followed up 81 cases, followed up for 1 to 157 months, an average of 6.8 years. In 81 cases of artificial vascular graft, 4 cases of graft thromboembolism, including 1 case of left iliac artery transplantation 8 months after the occurrence of delayed thromboembolism left lower extremity gangrene left iliac joint release. 3 cases of iliac vein graft thromboembolism 7 to 12 months after surgery, slightly swollen limbs. There were 74 cases with survival> 1 year, 61 cases> 3 years and 39 cases> 5 years. The remaining cases were still under follow-up. Eleven cases of tumor recurrence resection in the follow-up. Conclusions Excision of the primary or recurrent retroperitoneal tumor involving major vessels and the revascularization of large vessels is safe and safe. It can significantly improve the resection rate, reduce the recurrence rate and prolong the survival time.